The Claim

In adults with bipolar depression, adjunctive creatine monohydrate at 6 g daily for 6 weeks was not associated with a statistically significant improvement in mean Montgomery–Åsberg Depression Rating Scale (MADRS) scores compared to placebo in intention-to-treat analysis.

Source: A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
75score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Correlation
1 study reviewed
In plain English

A study found that taking 6 grams of creatine daily for 6 weeks did not produce a statistically significant change in depression symptom scores among adults with bipolar depression, compared to a placebo.

See the scientific wording

Adjunctive creatine monohydrate at 6 g daily for 6 weeks in adults with bipolar depression was not associated with a statistically significant improvement in mean Montgomery–Åsberg Depression Rating Scale (MADRS) scores compared to placebo in intention-to-treat analysis (p=0.560, Cohen’s d=0.231), indicating no clear effect on overall depressive symptom severity.

Why this might work

Creatine enters the brain and helps produce more energy for nerve cells by replenishing a key energy molecule. This energy supports nerve cell function, protects them from damage caused by harmful chemicals, and maintains communication between brain regions that control mood. When energy levels improve and damage decreases, nerve cells in mood-regulating areas work better, which should reduce depression symptoms.

Supported mechanismbased on 1 study

What the research says

1 study

  1. Study: A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression

    The primary outcome of the study was change in MADRS score, and the intention-to-treat analysis showed no significant difference between creatine and placebo. This directly contradicts any claim that creatine reliably reduces depressive symptoms on average.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.